GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 54 filers reported holding GENERATION BIO CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270,508 | -31.1% | 71,377 | -0.1% | 0.00% | – |
| Q2 2023 | $392,854 | +121904.3% | 71,428 | -4.7% | 0.00% | – |
| Q1 2023 | $322 | +10.3% | 74,912 | +0.8% | 0.00% | – |
| Q4 2022 | $292 | -99.9% | 74,331 | +5.2% | 0.00% | -100.0% |
| Q3 2022 | $375,000 | -11.8% | 70,662 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $425,000 | +31.2% | 64,777 | +46.7% | 0.00% | – |
| Q1 2022 | $324,000 | +4.2% | 44,156 | +0.6% | 0.00% | – |
| Q4 2021 | $311,000 | -72.5% | 43,877 | -2.7% | 0.00% | -100.0% |
| Q3 2021 | $1,131,000 | -2.5% | 45,105 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $1,160,000 | -3.4% | 43,135 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $1,201,000 | +209.5% | 42,195 | +208.0% | 0.00% | +100.0% |
| Q4 2020 | $388,000 | +11.8% | 13,700 | +22.0% | 0.00% | 0.0% |
| Q3 2020 | $347,000 | – | 11,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $31,379,244 | 4.86% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $3,875,415 | 0.71% |
| Artal Group S.A. | 2,814,191 | $10,666 | 0.46% |
| PFM Health Sciences, LP | 2,514,443 | $9,529,739 | 0.45% |
| Yiheng Capital Management, L.P. | 1,666,181 | $6,314,826 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 356,740 | $1,352,045 | 0.26% |
| EcoR1 Capital, LLC | 2,046,867 | $7,757,626 | 0.26% |
| Bellevue Group AG | 3,617,080 | $13,708,733 | 0.22% |
| SVB FINANCIAL GROUP | 25,034 | $94,879 | 0.18% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,681 | $142,811 | 0.03% |